Wall St. edges down; healthcare sinks and Intel climbs

Axiom Capital Starts Match Group (MTCH) at Buy

Axiom Capital initiated coverage on Match Group (NASDAQ: MTCH) with a Buy rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Match Group click here. For more ratings news on Match Group click here.

Shares of Match Group closed at $15.20 yesterday.

BTIG Starts Match Group (MTCH) at Sell

BTIG initiated coverage on Match Group (NASDAQ: MTCH) with a Sell rating and a price target of $11. Analyst Brandon Ross thinks Tinder is cannibalizing the rest of its business.

"We believe the biggest risk to Match Group is what we call the Tinder Catch-22 which is that as MTCH... More

Cowen Reiterates Market Perform on Intel (INTC) Based on Growth Prospects

Cowen reiterated a Market Perform rating on Intel (NASDAQ: INTC), and raised the price target to $35.00 (from $34.00), on better growth prospects in DCG and GM tailwinds. INTC as a whole is less reliant on PCs than in the past and its PC business is... More

UnitedHealth Group (UNH) Announces Substantial Losses; Mizuho Securities Cuts Price Target to $131

Mizuho Securities maintained a Buy rating on UnitedHealth Group (NYSE: UNH), and cut the price target to $131.00 (from $150.00), following the company's exchange losses and updated guidance. Management reported two sets of losses yesterday. Those affecting 4Q15, and those affecting 2016. Of the total of $700mm... More

salesforce.com (CRM) Reports Record Revenue; Roth Capital Reiterates Buy

Roth Capital reiterated a Buy rating on salesforce.com (NYSE: CRM), and raised the price target to $93.00 (from $80.00), following the company's 3Q earnings report. Revenues grew 24.0% y/y to a record $1.712B, and drove pro forma EPS of $0.21. These results beat Roth's estimates of $1.698B... More

Nomura Securities Reiterates Buy on salesforce.com (CRM) Following Solid 3Q Results

Nomura Securities reiterated a Buy rating and $90.00 price target on salesforce.com (NYSE: CRM) following the company's 3Q earnings report. Salesforce reported billings of $1.52bn, up 21% yoy and 2% above the consensus estimate of $1.49bn. Additionally, Salesforce posted revenues of $1.71bn (+24% yoy), above consensus of $1.70bn.... More

Canaccord Genuity Says salesforce.com (CRM) is 'Structural Buy'; Raises Price Target to $95

Canaccord Genuity reiterated a Buy rating on salesforce.com (NYSE: CRM), and raised the price target to $95.00 (from $85.00), following the company's 3Q earnings report. CRM reported revenue and non-GAAP EPS of $1.71B and $0.21, which were respectively $12M and $0.02 ahead of Cannaccord's estimates.

Analyst Richard... More

salesforce.com (CRM) Reports Solid 3Q Across the Board; Needham & Company Raises Price Target to $90

Needham & Company reiterated a Buy rating on salesforce.com (NYSE: CRM), and raised the price target to $90.00 (from $85.00), following the company's 3Q earnings report. CRM reported solid results across the board. The quarter was highlighted by 21% billings growth, which suggests healthy fundamentals, the strength of Salesforce's... More

Mizuho Securities Raises Price Target Following salesforce.com (CRM) 3Q Beat

Mizuho Securities reiterated a Buy rating on salesforce.com (NYSE: CRM), and raised the price target to $90.00 (from $80.00), following the company's 3Q earnings report. The company reported revenues of $1.71bn and EPS of $0.21, which were both ahead of consensus of $1.70bn and $0.19, respectively.... More